ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 060

Impact of Social Determinants of Health on Outcomes in Pediatric Uveitis

erin stahl1, ashley lytch2, Janelle Noel-Macdonnell2 and ashley cooper1, 1Children's Mercy Kansas City, Kansas City, MO, 2Children's Mercy Kansas City

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Quality, Health Services, and Education Research I

Session Time: 6:00PM-7:00PM

Background/Purpose: Chronic uveitis is an immune-mediated disease that can cause severe complications, including blindness. Chronic uveitis care involves numerous medical visits, frequent laboratory monitoring and complex medication regimens that impose considerable expense. Social determinants of health (SDoH) influence health outcomes but little is known about the specific impacts of SDoH on outcomes in pediatric uveitis. The aim of this study is to assess the extent to which various SDoH impact visual outcomes in pediatric uveitis through a survey of patients treated in a multi-disciplinary pediatric uveitis clinic.

Methods: Patients from a multidisciplinary uveitis clinic at a large children’s hospital in the Midwestern United States were prospectively enrolled and completed a novel survey designed to assess various SDoH. Demographics, uveitis clinical features, treatments, clinical outcomes and complications were obtained through retrospective chart review.  The Child Opportunity Index (COI), a composite measure of neighborhood opportunities influencing child health, was determined for each participant based on home zip code. Descriptive statistics were used to describe the patient population. The impact of various SDoH on outcomes was assessed using Wilcoxon rank-sum test for continuous variables and chi-square or Fisher’s exact test for categorical variables.

Results: Sixty-four subjects were enrolled. Demographics and clinical characteristics of the population are described in table 1. Most subjects were white (84.4%), non-Hispanic (85.9%) and female (67.2%). Juvenile idiopathic arthritis (JIA) was the most common underlying condition. Thirty-nine (60.9%) had at least one uveitis complication, 15 (23.4%) required eye surgery, and 15 (23.4%) had moderate or severe visual impairment (best corrected visual acuity (BCVA) worse than 20/50) in at least one eye. Subjects who identified as black or African American were more likely to have ocular complications of uveitis (p=0.018). Median LogMAR BCVA among subjects with low or very low COI was worse compared to those with moderate, high or very high COI (0.18 (IQR 0,0.48) vs 0 (IQR 0,0.1), p=0.046), though difference in rates of moderate or severe visual impairment (BCVA worse than 20/50 (LogMAR 0.4) in at least one eye)) between the groups did not reach statistical significance (p=0.322). Other SDoH evaluated were not associated with statistically significant differences in visual acuity, complications or surgery.

Conclusion: Among children with uveitis followed in a specialized, multidisciplinary clinic, outcomes were similar across most social determinants of health assessed. Black race was associated with more uveitis complications and children with lower COI had slightly worse visual acuity, though not reaching the threshold of a clinically significant visual impairment. These results may not be translatable to all patient populations given the highly coordinated care provided in our clinic setting.

Subject Demographics and Clinical CharacteristicsSupporting image 1

Social Determinants of Health Impact and Clinical OutcomesSupporting image 2


Disclosures: e. stahl: None; a. lytch: None; J. Noel-Macdonnell: None; a. cooper: None.

To cite this abstract in AMA style:

stahl e, lytch a, Noel-Macdonnell J, cooper a. Impact of Social Determinants of Health on Outcomes in Pediatric Uveitis [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/impact-of-social-determinants-of-health-on-outcomes-in-pediatric-uveitis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-social-determinants-of-health-on-outcomes-in-pediatric-uveitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology